Guardian Pharmacy Services (NYSE:GRDN) Trading Down 5% – Here’s Why

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s share price fell 5% during trading on Thursday . The stock traded as low as $19.23 and last traded at $19.24. 140,536 shares were traded during mid-day trading, a decline of 26% from the average session volume of 189,088 shares. The stock had previously closed at $20.26.

Wall Street Analyst Weigh In

A number of research firms have issued reports on GRDN. Raymond James assumed coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They issued an “outperform” rating and a $21.00 target price for the company. Truist Financial lifted their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, November 15th. Finally, Stephens started coverage on shares of Guardian Pharmacy Services in a report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price objective on the stock.

Guardian Pharmacy Services Price Performance

The company has a fifty day simple moving average of $21.82.

Guardian Pharmacy Services (NYSE:GRDN) last posted its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The business had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. As a group, equities analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Steven D. Cosler bought 7,000 shares of the company’s stock in a transaction on Tuesday, November 19th. The stock was acquired at an average cost of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the transaction, the director now directly owns 17,713 shares in the company, valued at $375,869.86. This trade represents a 65.34 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Institutional Trading of Guardian Pharmacy Services

Hedge funds have recently made changes to their positions in the stock. Stephens Inc. AR bought a new stake in Guardian Pharmacy Services during the third quarter worth about $189,000. Virtu Financial LLC bought a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $279,000. Barclays PLC purchased a new stake in Guardian Pharmacy Services in the third quarter worth approximately $311,000. Point72 DIFC Ltd bought a new position in Guardian Pharmacy Services during the third quarter valued at approximately $573,000. Finally, Royce & Associates LP purchased a new position in shares of Guardian Pharmacy Services during the third quarter worth approximately $1,260,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.